Ausgabe 9/2012
Inhalt (25 Artikel)
Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes
Monica Bernal, Francisco Ruiz-Cabello, Angel Concha, Annette Paschen, Federico Garrido
Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth
Matthew R. Porembka, Jonathan B. Mitchem, Brian A. Belt, Chyi-Song Hsieh, Hyang-Mi Lee, John Herndon, William E. Gillanders, David C. Linehan, Peter Goedegebuure
Photodynamic therapy–generated cancer vaccine elicits acute phase and hormonal response in treated mice
Mladen Korbelik, Soroush Merchant
IRX-2, a novel immunotherapeutic, enhances and protects NK-cell functions in cancer patients
B. Schilling, E. S. Halstead, P. Schuler, M. Harasymczuk, J. E. Egan, T. L. Whiteside
Quality of life during dendritic cell vaccination against metastatic renal cell carcinoma
Nicolai Leonhartsberger, Reinhold Ramoner, Claudia Falkensammer, Andrea Rahm, Hubert Gander, Lorenz Höltl, Martin Thurnher
Autologous dendritic cell vaccine for estrogen receptor (ER)/progestin receptor (PR) double-negative breast cancer
Chun-Jian Qi, Yong-Ling Ning, Ye-Shan Han, Hai-Yan Min, Heng Ye, Yu-Lan Zhu, Ke-Qing Qian
Interleukin-1β enhances the production of soluble MICA in human hepatocellular carcinoma
Keisuke Kohga, Tomohide Tatsumi, Hinako Tsunematsu, Satoshi Aono, Satoshi Shimizu, Takahiro Kodama, Hayato Hikita, Masashi Yamamoto, Tsugiko Oze, Hiroshi Aketa, Atsushi Hosui, Takuya Miyagi, Hisashi Ishida, Naoki Hiramatsu, Tatsuya Kanto, Norio Hayashi, Tetsuo Takehara
Genetic variation in IL28B is associated with the development of hepatitis B-related hepatocellular carcinoma
Shan Ren, Junfeng Lu, Xiaofei Du, Yanxiang Huang, Lina Ma, Honglei Huo, Xinyue Chen, Lai Wei
Differential effects of low-dose decitabine on immune effector and suppressor responses in melanoma-bearing mice
Pierre L. Triozzi, Wayne Aldrich, Susan Achberger, Selvarangan Ponnazhagan, Oscar Alcazar, Yogen Saunthararajah
Expression of IL-15 in NK cells results in rapid enrichment and selective cytotoxicity of gene-modified effectors that carry a tumor-specific antigen receptor
Christiane Sahm, Kurt Schönfeld, Winfried S. Wels
Evaluation of CTLA-4 expression and relevance as a novel prognostic factor in patients with non-small cell lung cancer
Sandra Salvi, Vincenzo Fontana, Simona Boccardo, Domenico Franco Merlo, Edoardo Margallo, Stefania Laurent, Anna Morabito, Erika Rijavec, Maria Giovanna Dal Bello, Marco Mora, Giovanni Battista Ratto, Francesco Grossi, Mauro Truini, Maria Pia Pistillo
IL-15 augments antitumoral activity of an ErbB2/HER2 cancer vaccine targeted to professional antigen-presenting cells
Ute E. Burkhardt, Arjen Sloots, Vera Jakobi, Wei-Zen Wei, Federica Cavallo, Björn-Philipp Kloke, Winfried S. Wels
A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions
Peggy J. de Vos van Steenwijk, Tamara H. Ramwadhdoebe, Margriet J. G. Löwik, Caroline E. van der Minne, Dorien M. A. Berends-van der Meer, Lorraine M. Fathers, A. Rob P. M. Valentijn, Jaap Oostendorp, Gert Jan Fleuren, Bart W. J. Hellebrekers, Marij J. P. Welters, Mariette I. van Poelgeest, Cornelis J. M. Melief, Gemma G. Kenter, Sjoerd H. van der Burg
The roles of mast cells in anticancer immunity
Dyana K. Dalton, Randolph J. Noelle
How to connect an IgE-driven response with CTL activity?
Barbara Platzer, Eleonora Dehlink, Shannon J. Turley, Edda Fiebiger
Involvement of eosinophils in the anti-tumor response
Solène Gatault, Fanny Legrand, Marie Delbeke, Sylvie Loiseau, Monique Capron
Animal models for IgE-meditated cancer immunotherapy
Tracy R. Daniels, Otoniel Martínez-Maza, Manuel L. Penichet
Recombinant IgE antibodies for passive immunotherapy of solid tumours: from concept towards clinical application
Sophia N. Karagiannis, Debra H. Josephs, Panagiotis Karagiannis, Amy E. Gilbert, Louise Saul, Sarah M. Rudman, Tihomir Dodev, Alexander Koers, Philip J. Blower, Christopher Corrigan, Andrew J. Beavil, James F. Spicer, Frank O. Nestle, Hannah J. Gould
Recombinant IgE antibody engineering to target EGFR
Edzard Spillner, Melanie Plum, Simon Blank, Michaela Miehe, Josef Singer, Ingke Braren
Hypersensitivity to antineoplastic agents: mechanisms and treatment with rapid desensitization
Mariana Castells, Maria del Carmen Sancho-Serra, Maria Simarro
Activation-induced cytidine deaminase (AID) linking immunity, chronic inflammation, and cancer
Diana Mechtcheriakova, Martin Svoboda, Anastasia Meshcheryakova, Erika Jensen-Jarolim
Ninth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), Siena, Italy, October 19–22, 2011: New perspectives in the immunotherapy of cancer
Michele Maio, Hugues J. M. Nicolay, Paolo A. Ascierto, Filippo Belardelli, Roberto Camerini, Mario P. Colombo, Paola Queirolo, Ruggero Ridolfi, Vincenzo Russo, Giulia Parisi, Ester Fonsatti, Michael Papamichail, Giorgio Parmiani